![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Company Failed to Check Out Patient’s Drug Complaint, FDA Says
Company Failed to Check Out Patient’s Drug Complaint, FDA Says
A Texas drugmaker was flagged by the FDA for failing to follow up on a patient’s complaint.
The company, Neos Therapeutics, of Grand Prairie, did not investigate a complaint of dizziness and difficulty sleeping after taking Adzenys (amphetamine), an extended-release tablet for treating attention deficit hyperactivity disorder in patients 6 years and above.
The company also did not document why it didn’t look into the complaint, the FDA said in a Form 483 report.
Upcoming Events
-
21Oct